Selective Inhibition of Proofreading Exonucleases: The Central Role in Obesity-Associated Carcinogenesis

Area of Science:

• Molecular Biology
• Metabolic Regulation
• Cancer Biology

Background:

• Obesity disrupts cellular energy balance, impairing Adenosine 5'-monophosphate-activated protein kinase (AMPK) function.
• Impaired AMPK leads to reduced ATP, elevated Adenosine Monophosphate (AMP), and cellular energy stress, impacting DNA replication fidelity.

Purpose of the Study:

• To investigate the link between metabolic dysregulation in obesity and genomic instability.
• To elucidate the role of AMPK and Adenosine Monophosphate (AMP) in DNA replication accuracy and carcinogenesis.

Main Methods:

• Analysis of the interaction between Adenosine Monophosphate (AMP) and DNA polymerases ε (Pol ε) and δ (Pol δ).
• Examination of how cellular energy stress affects DNA replication fidelity and mutation accumulation.
• Evaluation of therapeutic interventions targeting AMPK in the context of obesity-associated cancer.

Main Results:

• Elevated Adenosine Monophosphate (AMP) directly inhibits the proofreading exonucleases of DNA polymerases ε (Pol ε) and δ (Pol δ), increasing replication errors.
• This loss of genomic accuracy contributes to the accumulation of mutations that drive carcinogenic evolution.
• Interventions activating AMPK (e.g., weight loss, exercise, metformin) restore ATP production, lower AMP, and preserve genomic integrity.

Conclusions:

• Energy metabolism and DNA replication fidelity are mechanistically coupled at the DNA polymerase active site.
• Mutation rate is an adaptive metabolic phenotype modulated by Adenosine Monophosphate (AMP) levels.
• AMPK activation is a viable strategy for preventing obesity-associated cancers by maintaining genomic stability.